Cortalix

Groningen, Netherlands · Founded 2023 · Privately Held (backing)

Developer of a biotechnological platform designed for single-domain antibody (sdAb) discovery and development. Cortalix is based in Groningen, Netherlands and was founded in 2023. It has raised $1.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$1.3M
Last round
—

Who backs Cortalix?

6 investors
InvestorType
Rabo InvestmentsOther
Coöperatieve Rabobank.Other
RUG VenturesOther
Chaperone Pharma—
Coöperatieve Rabobank—
Future Tech Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cortalix investors

6 investors are on record for Cortalix, including Rabo Investments, Coöperatieve Rabobank., RUG Ventures and Chaperone Pharma.

Free account
More of Cortalix with a free account
  • ·Watch Cortalix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Cortalix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View